A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan · Delayed Price · Currency is TWD 82.90
-0.50 (-0.60%)
At close: Feb 11, 2026
A Plus Biotechnology Market Cap
A Plus Biotechnology has a market cap or net worth of 2.82 billion as of February 13, 2026. Its market cap has increased by 5.94% in one year.
Market Cap
2.82B
Enterprise Value
2.33B
Revenue
825.52M
Ranking
n/a
PE Ratio
15.41
Stock Price
82.90
Market Cap Chart
Since January 6, 2023, A Plus Biotechnology's market cap has increased from 1.52B to 2.82B, an increase of 85.39%. That is a compound annual growth rate of 22.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.82B | -4.44% |
| Dec 31, 2025 | 2.96B | 20.95% |
| Dec 31, 2024 | 2.44B | 77.04% |
| Dec 29, 2023 | 1.38B | -9.40% |
| Jan 6, 2023 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonraybio | 4.25B |
| InnoCare Optoelectronics | 3.26B |
| Medimaging Integrated Solution | 3.25B |
| WeLeader Biomedical | 3.23B |
| Applied BioCode | 2.47B |
| Dynamic Medical Technologies | 2.37B |
| Diamond Biotechnology | 2.36B |
| Wellell | 2.33B |